Thank you for your interest in attending ‘AI and Big Data in Cancer: From Innovation to Impact’.
As the spread of COVID-19 continues and the situation remains uncertain, we believe it would be irresponsible to proceed as scheduled for 15-17 November in Boston, USA so we have made the difficult decision to cancel the conference.
We are grateful to all our chairs, speakers, panellists, submitting authors, and registered delegates for their support of the conference.
The future of medicine is data-driven and AI-enabled. Artificial intelligence will impact diagnosis, treatment decisions and patient care. Learn from others along the value-chain to understand how to effectively translate technology, data and analytic innovations into clinical practices and patient benefits and find the right partners to move your innovations forward.
Poster Awards: Submit abstracts here.
Join the conversation #AICancer2020
from the insights of leading researchers, clinicians, technologists, entrepreneurs, regulators, and payers
the conversation and network with leaders and innovators across industry, academia, and government
your stay when visiting the Westin Boston Waterfront during the conference
the groundbreaking symposium bridging technological innovation and clinical application
Elsevier seeks to promote and facilitate an open conversation between disparate stakeholders to accelerate the implementation of AI in oncology care.
Get the latest conference updates by signing up to our event newsletter
Have question about the conference or issues with registration
Exhibit with us
To discuss your requirements or to book sponsorship or exhibit space please contact:
Carolina Ulloa Parra
Conference Sponsorship Sales Executive
STM Journals | Elsevier
Radarweg 29 | 1043NX Amsterdam | The Netherlands
T: +31 20 485 2125 | E-mail: firstname.lastname@example.org